Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $177,831 - $218,265
7,629 New
7,629 $213,000
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $6,047 - $7,429
191 Added 2.05%
9,508 $321,000
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $5,176 - $6,691
-170 Reduced 1.79%
9,317 $325,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $23,194 - $30,038
-809 Reduced 7.86%
9,487 $289,000
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $93,333 - $116,186
-3,260 Reduced 24.05%
10,296 $338,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $385,668 - $515,128
13,556 New
13,556 $410,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.